Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Greenberg

Emergency Medicine West Bloomfield, MI Medical Doctor

NPI 1144562968 CMS profile 5258443

2300 Haggerty Rd, Ste 1190, West Bloomfield, MI 48323

Open in the dashboard

General payments

$3,230

92 records reported · program years 2019–2025

Research payments

$125

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Greenberg of West Bloomfield, MI is reported in the CMS Open Payments database as having received $3,230 across 92 general payments and $125 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $285 13
2024 General $227 11
2023 General $311 13
2022 General $49 2
2021 General $51 3
2020 General $1,174 10
2019 General $1,134 40
2019 Research $125 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Greenberg
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Eric Greenberg were reported at $285. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Eric Greenberg Emergency Medicine median Middle half National median
2019 $1,134 $51 $18–$128 $163
2020 $1,174 $29 $16–$99 $114
2021 $51 $40 $18–$124 $132
2022 $49 $49 $20–$134 $149
2023 $311 $51 $22–$142 $160
2024 $227 $52 $22–$150 $164
2025 $285 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Titan Pharmaceuticals, Inc. $966 3 payments
  2. Indivior Inc. $523 18 payments
  3. Alkermes, Inc. $350 14 payments
  4. Janssen Pharmaceuticals, Inc $247 10 payments
  5. Orexo US, Inc. $209 8 payments
  6. Novo Nordisk Inc $203 8 payments
  7. Teva Pharmaceuticals USA, Inc. $186 9 payments
  8. Axsome Therapeutics, Inc. $169 7 payments
  9. Amgen Inc. $125 1 payment
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $60 2 payments
  11. Other $193 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,449 89 payments
  2. Travel and Lodging $767 1 payment
  3. Education $15 2 payments
Products named General payments · program years 2019–2025
  1. Probuphine $966 3 payments
  2. SUBLOCADE Oud $378 11 payments
  3. VIVITROL $350 14 payments
  4. SPRAVATO $231 9 payments
  5. Zubsolv $209 8 payments
  6. Ajovy $173 7 payments
  7. Auvelity $169 7 payments
  8. SUBLOCADE Oud $145 7 payments
  9. EVENITY $125 1 payment
  10. Ozempic $120 1 payment
  11. Other $373 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Indivior Inc. $125 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

151

Median for Emergency Medicine: 88

Drug cost

$127,854

Median for Emergency Medicine: $590

Branded share of claims

85.4%

Median for Emergency Medicine: 33.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Spravato Esketamine Hcl Brand 107 $123,773
Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl Brand 22 $2,322
Tiagabine Hcl Generic 11 $1,653
Quetiapine Fumarate Generic 11 $106

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$49,102

Medicare's payments for the services billed

Medicare patients

22

Average age 55

Services billed

1,541

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 59%
Arthritis 50%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VIVITROL
  • Alkermes, Inc. $54
$54 — —
SUBLOCADE
  • Indivior Inc. $46
$46 — —
SPRAVATO
  • Janssen Pharmaceuticals, Inc $37
$37 107 —
MAVYRET
  • AbbVie, Inc. $32
$32 — —
Auvelity
  • Axsome Therapeutics, Inc. $28
$28 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record